Dr. Bob Lahita discusses the possibility of experiencing dangers from the Johnson & & Johnson vaccine, as the government halts its rollout.
Federal health companies on Tuesday recommended a pause on administering the Johnson & & Johnson single-dose vaccine while they dig deeper into reports from several ladies between the ages of 18 and 48 who stated they fell ill with “a serious and unusual type of blood clot”– as explained by the CDC– within two weeks of getting the vaccine. One of the females passed away.
Nearly 7 million dosages of the vaccine have actually been administered in the U.S.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
The CDC is set to assemble a conference on Wednesday to evaluate the cases.
In a declaration, Johnson & & Johnson stated the health and wellness of individuals who utilize its products is its number one priority.
CLICK HERE TO READ MORE ON FOX BUSINESS
Even without Johnson & & Johnsons vaccine, White House authorities said they stay on track to have adequate materials to vaccinate most American adults by the summer season.
“We think theres adequate vaccine in the system– Moderna and Pfizer– for all Americans who want to get vaccinated by May 31 to do so,” said Jeff Zients, the White Houses COVID-19 reaction planner.
The Associated Press contributed to this report.
Pharmaceutical huge Pfizer stated Tuesday that it is prepared to increase production of its COVID-19 vaccine after U.S. federal firms recommended a pause on administering injections of the Johnson & & Johnson variation over health dangers.
Moderna Inc. likewise reacted to the Johnson & & Johnson problems, emphasizing the security of its vaccine.
ADVANTAGES OF JOHNSON & & JOHNSON VACCINE STILL OUTWEIGH THE RISKS: DR. NESHEIWAT
In a Twitter post, Pfizer CEO Albert Bourla said the business can provide 10% more dosages than previously accepted– an overall of 220 million– by the end of May. He also stated Pfizer will have the complete 300 million dosages set up for shipment in the U.S. by the end of July, two weeks early.
The additional dosages of Pfizer may assist offset a potential decrease in expected vaccine doses, depending on what health authorities decide to do with the Johnson & & Johnson vaccine moving on.